LONN.SW

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally.

Lonza Group AG (LONN.SW) is a healthcare company listed on SIX Swiss Exchange, traded in CHF. Over the past year it moved between CHF 454.60 and CHF 650.00, and it pays a dividend once a year.

• Healthcare
• Diagnostics & Research
• Basel, Switzerland
• 20.1K employees
• Led by Wolfgang Wienand Ph.D.